LUNG Q3 2020 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$72M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$11M+16.6% YoY

Gross Profit

$7M70.3% margin

Operating Income

-$5M-50.4% margin

Net Income

-$4M-36.4% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+188.9%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$518,000

Balance Sheet

Total Assets

$71M

Total Liabilities

$71M

Stockholders' Equity

$709,999

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$9M	+16.6%
Gross Profit	$7M	$6M	+16.5%
Operating Income	-$5M	-$4M	-48.0%
Net Income	-$4M	-$4M	+11.0%

Geographic Segments

UNITED STATES

$5M50%

EMEA

$4M42%

Asia Pacific

$827,0008%